Vanda Pharmaceuticals Price Chart
Vanda Pharmaceuticals Volume Chart
Vanda Pharmaceuticals Market Segments
Premarket
| Open | $5.35 |
|---|---|
| Close | $5.35 |
| Low | $5.35 |
| Low Change | 0.00 (0.00%) |
| High | $5.35 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 300 |
| Dollar Volume | $1.61K |
Overnight
*No Trades in Segment
After Hours Yesterday
| Open | $5.36 |
|---|---|
| Close | $5.44 |
| Low | $5.36 |
| Low Change | 0.00 (0.00%) |
| High | $5.44 |
| High Change | +0.08 (+1.49%) |
| Range | $0.08 |
| Volume | 134.767K |
| Dollar Volume | $733.13K |
Regular Trading Hours Yesterday
| Open | $5.30 |
|---|---|
| Close | $5.35 |
| Low | $5.25 |
| Low Change | -0.05 (-0.94%) |
| High | $5.43 |
| High Change | +0.13 (+2.45%) |
| Range | $0.18 |
| Volume | 727.599K |
| Dollar Volume | $3.89M |
Premarket Yesterday
| Open | $5.40 |
|---|---|
| Close | $5.35 |
| Low | $5.35 |
| Low Change | -0.05 (-0.93%) |
| High | $5.43 |
| High Change | +0.03 (+0.62%) |
| Range | $0.08 |
| Volume | 1.757K |
| Dollar Volume | $9.40K |
Vanda Pharmaceuticals News
3 months agoinvesting.comVanda Pharmaceuticals shares rise on Nereus commercial launch
5 months agoinvesting.comVanda Pharmaceuticals stock surges after the FDA approves its new Bipolar I drug
7 months agoinvesting.comVanda Pharmaceuticals stock falls after FDA rejects jet lag treatment application
7 months agoinvesting.comVanda Pharmaceuticals stock soars after FDA approval of motion sickness drug
7 months agobenzinga.comVanda Pharmaceuticals, One Stop Systems And 3 Stocks To Watch Heading Into Wednesday
7 months agobenzinga.comWhy Is Vanda Pharmaceuticals' (VNDA) Stock Trending Overnight?
7 months agoinvesting.comUS FDA approves Vanda Pharmaceuticals’ motion sickness drug
Vanda Pharmaceuticals Top Trades
Vanda Pharmaceuticals's top trade so far today returned +0.00%, while the top short trade returned 0.00%.
Vanda Pharmaceuticals Moving Averages
| 5 Day Moving Average (SMA5) | $5.38 |
|---|---|
| 10 Day Moving Average (SMA10) | $5.63 |
| 20 Day Moving Average (SMA20) | $5.91 |
| 50 Day Moving Average (SMA50) | $6.04 |
| 100 Day Moving Average (SMA100) | $6.75 |
| 200 Day Moving Average (SMA200) | $6.53 |
Vanda Pharmaceuticals Statistics
| Average Volume (30 Days) | 916.22K |
|---|---|
| P/E Ratio (Current) | -1.34 |
| EPS (Current) | -$3.98 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$127.30M |
| Cash Ratio | 0.40 |
| Current Ratio | 2.16 |
| Quick Ratio | 2.15 |
| Debt to Equity | 0.01 |
| Enterprise Value | $271.48M |
| EV to EBITDA | -1.79 |
| EV to Sales | 1.25 |
| Price to Book | 1.15 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 1.48 |
| Return on Assets | -0.55% |
| Return on Equity | -0.85% |
Vanda Pharmaceuticals Stock Splits
There have been no stock splits for Vanda Pharmaceuticals (VNDA).
Vanda Pharmaceuticals Dividends
There have been no dividends for Vanda Pharmaceuticals (VNDA).